IES20060154A2 - Cosmetic compositions - Google Patents

Cosmetic compositions

Info

Publication number: IES20060154A2
Authority: IE; Ireland
Prior art keywords: skin; gly; composition; sequence; peptide
Prior art date: 2006-03-02

Application number

IE20060154A

Other languages

English (en)

Inventor

Aurelie Laloeuf

Original Assignee

Oriflame Global Technical Ct L

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-03-02

Filing date

2006-03-02

Publication date

2007-09-05

2006-03-02 Application filed by Oriflame Global Technical Ct L filed Critical Oriflame Global Technical Ct L

2006-03-02 Priority to IE20060154A priority Critical patent/IES20060154A2/en

2007-03-02 Priority to SE0700513A priority patent/SE531484C2/sv

2007-09-05 Publication of IES20060154A2 publication Critical patent/IES20060154A2/en

Links

239000000203 mixture Substances 0.000 title claims abstract description 60
239000002537 cosmetic Substances 0.000 title claims abstract description 22
108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 76
240000000581 Triticum monococcum Species 0.000 claims abstract description 14
230000000699 topical effect Effects 0.000 claims abstract description 13
235000003532 Triticum monococcum subsp monococcum Nutrition 0.000 claims abstract description 12
WVNFNPGXYADPPO-BQBZGAKWSA-N Arg-Gly-Ser Chemical compound NC(N)=NCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O WVNFNPGXYADPPO-BQBZGAKWSA-N 0.000 claims abstract description 9
108010069926 arginyl-glycyl-serine Proteins 0.000 claims abstract description 9
OGNHOGPWQTWKGQ-VGWMRTNUSA-N (2S)-5-amino-2-[[(2S)-1-[2-[[(2S)-5-amino-2-[[(2S)-1-(2-aminoacetyl)pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]acetyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoic acid Chemical compound NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N1[C@H](C(=O)N[C@@H](CCC(N)=O)C(O)=O)CCC1 OGNHOGPWQTWKGQ-VGWMRTNUSA-N 0.000 claims abstract description 7
KDJVKDYFFTWHBO-WDSKDSINSA-N L-Cys-Gly disulfide dizwitterion Chemical compound OC(=O)CNC(=O)[C@@H](N)CSSC[C@H](N)C(=O)NCC(O)=O KDJVKDYFFTWHBO-WDSKDSINSA-N 0.000 claims abstract description 7
238000004519 manufacturing process Methods 0.000 claims abstract description 4
102000004196 processed proteins & peptides Human genes 0.000 claims description 24
108010016626 Dipeptides Proteins 0.000 claims description 3
239000000539 dimer Substances 0.000 claims description 2
206010051246 Photodermatosis Diseases 0.000 abstract description 11
238000007665 sagging Methods 0.000 abstract description 9
230000001413 cellular effect Effects 0.000 abstract description 6
230000007423 decrease Effects 0.000 abstract description 5
230000003711 photoprotective effect Effects 0.000 abstract 1
230000001172 regenerating effect Effects 0.000 abstract 1
210000003491 skin Anatomy 0.000 description 66
230000000694 effects Effects 0.000 description 26
206010040954 Skin wrinkling Diseases 0.000 description 24
102000008186 Collagen Human genes 0.000 description 21
108010035532 Collagen Proteins 0.000 description 21
229920001436 collagen Polymers 0.000 description 21
230000032683 aging Effects 0.000 description 16
238000000034 method Methods 0.000 description 16
230000037303 wrinkles Effects 0.000 description 15
210000004027 cell Anatomy 0.000 description 10
102000019197 Superoxide Dismutase Human genes 0.000 description 8
108010012715 Superoxide dismutase Proteins 0.000 description 8
210000002950 fibroblast Anatomy 0.000 description 8
229940068196 placebo Drugs 0.000 description 8
239000000902 placebo Substances 0.000 description 8
102000010834 Extracellular Matrix Proteins Human genes 0.000 description 7
108010037362 Extracellular Matrix Proteins Proteins 0.000 description 7
208000003251 Pruritus Diseases 0.000 description 7
230000003859 lipid peroxidation Effects 0.000 description 7
102000004169 proteins and genes Human genes 0.000 description 7
108090000623 proteins and genes Proteins 0.000 description 7
102000016938 Catalase Human genes 0.000 description 6
108010053835 Catalase Proteins 0.000 description 6
230000006315 carbonylation Effects 0.000 description 6
238000005810 carbonylation reaction Methods 0.000 description 6
210000002744 extracellular matrix Anatomy 0.000 description 6
230000008845 photoaging Effects 0.000 description 6
150000003254 radicals Chemical class 0.000 description 6
239000003642 reactive oxygen metabolite Substances 0.000 description 6
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
239000006071 cream Substances 0.000 description 5
230000003810 hyperpigmentation Effects 0.000 description 5
208000000069 hyperpigmentation Diseases 0.000 description 5
230000036542 oxidative stress Effects 0.000 description 5
230000035882 stress Effects 0.000 description 5
FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 4
230000001153 anti-wrinkle effect Effects 0.000 description 4
230000003078 antioxidant effect Effects 0.000 description 4
230000015572 biosynthetic process Effects 0.000 description 4
239000000835 fiber Substances 0.000 description 4
239000000499 gel Substances 0.000 description 4
230000014509 gene expression Effects 0.000 description 4
238000012744 immunostaining Methods 0.000 description 4
230000008569 process Effects 0.000 description 4
230000037394 skin elasticity Effects 0.000 description 4
230000002195 synergetic effect Effects 0.000 description 4
238000003786 synthesis reaction Methods 0.000 description 4
239000012099 Alexa Fluor family Substances 0.000 description 3
102000012422 Collagen Type I Human genes 0.000 description 3
108010022452 Collagen Type I Proteins 0.000 description 3
206010013786 Dry skin Diseases 0.000 description 3
102000004190 Enzymes Human genes 0.000 description 3
108090000790 Enzymes Proteins 0.000 description 3
102100028314 Filaggrin Human genes 0.000 description 3
101710088660 Filaggrin Proteins 0.000 description 3
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
239000004480 active ingredient Substances 0.000 description 3
230000003712 anti-aging effect Effects 0.000 description 3
239000003963 antioxidant agent Substances 0.000 description 3
230000008901 benefit Effects 0.000 description 3
230000037336 dry skin Effects 0.000 description 3
230000006353 environmental stress Effects 0.000 description 3
238000009472 formulation Methods 0.000 description 3
238000003125 immunofluorescent labeling Methods 0.000 description 3
238000005259 measurement Methods 0.000 description 3
238000012758 nuclear staining Methods 0.000 description 3
239000002304 perfume Substances 0.000 description 3
239000003755 preservative agent Substances 0.000 description 3
230000001737 promoting effect Effects 0.000 description 3
239000002904 solvent Substances 0.000 description 3
239000011885 synergistic combination Substances 0.000 description 3
101800000068 Antioxidant peptide Proteins 0.000 description 2
XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 2
102000016942 Elastin Human genes 0.000 description 2
108010014258 Elastin Proteins 0.000 description 2
HJARVELKOSZUEW-YUMQZZPRSA-N Gly-Pro-Gln Chemical compound [H]NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(O)=O HJARVELKOSZUEW-YUMQZZPRSA-N 0.000 description 2
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
240000007594 Oryza sativa Species 0.000 description 2
235000007164 Oryza sativa Nutrition 0.000 description 2
240000004808 Saccharomyces cerevisiae Species 0.000 description 2
235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 2
239000000524 Thiobarbituric Acid Reactive Substance Substances 0.000 description 2
150000001413 amino acids Chemical class 0.000 description 2
235000006708 antioxidants Nutrition 0.000 description 2
YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
230000015556 catabolic process Effects 0.000 description 2
230000005779 cell damage Effects 0.000 description 2
-1 colourants Substances 0.000 description 2
238000004624 confocal microscopy Methods 0.000 description 2
238000006731 degradation reaction Methods 0.000 description 2
230000003111 delayed effect Effects 0.000 description 2
230000006866 deterioration Effects 0.000 description 2
230000002542 deteriorative effect Effects 0.000 description 2
229940008099 dimethicone Drugs 0.000 description 2
239000004205 dimethyl polysiloxane Substances 0.000 description 2
235000013870 dimethyl polysiloxane Nutrition 0.000 description 2
229920002549 elastin Polymers 0.000 description 2
230000002255 enzymatic effect Effects 0.000 description 2
210000002615 epidermis Anatomy 0.000 description 2
BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
UQEAIHBTYFGYIE-UHFFFAOYSA-N hexamethyldisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)C UQEAIHBTYFGYIE-UHFFFAOYSA-N 0.000 description 2
229920006007 hydrogenated polyisobutylene Polymers 0.000 description 2
230000006872 improvement Effects 0.000 description 2
238000001727 in vivo Methods 0.000 description 2
230000001965 increasing effect Effects 0.000 description 2
230000002427 irreversible effect Effects 0.000 description 2
108010028309 kalinin Proteins 0.000 description 2
210000002510 keratinocyte Anatomy 0.000 description 2
239000007788 liquid Substances 0.000 description 2
230000007246 mechanism Effects 0.000 description 2
230000004060 metabolic process Effects 0.000 description 2
239000002207 metabolite Substances 0.000 description 2
239000008194 pharmaceutical composition Substances 0.000 description 2
229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
238000007388 punch biopsy Methods 0.000 description 2
235000009566 rice Nutrition 0.000 description 2
230000009759 skin aging Effects 0.000 description 2
230000037075 skin appearance Effects 0.000 description 2
241000894007 species Species 0.000 description 2
210000001519 tissue Anatomy 0.000 description 2
239000003981 vehicle Substances 0.000 description 2
PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 description 1
PQUXFUBNSYCQAL-UHFFFAOYSA-N 1-(2,3-difluorophenyl)ethanone Chemical compound CC(=O)C1=CC=CC(F)=C1F PQUXFUBNSYCQAL-UHFFFAOYSA-N 0.000 description 1
VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 1
DGZSVBBLLGZHSF-UHFFFAOYSA-N 4,4-diethylpiperidine Chemical compound CCC1(CC)CCNCC1 DGZSVBBLLGZHSF-UHFFFAOYSA-N 0.000 description 1
230000002407 ATP formation Effects 0.000 description 1
108090000312 Calcium Channels Proteins 0.000 description 1
102000003922 Calcium Channels Human genes 0.000 description 1
ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
230000005778 DNA damage Effects 0.000 description 1
231100000277 DNA damage Toxicity 0.000 description 1
238000002965 ELISA Methods 0.000 description 1
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
102000016359 Fibronectins Human genes 0.000 description 1
108010067306 Fibronectins Proteins 0.000 description 1
244000025221 Humulus lupulus Species 0.000 description 1
235000008694 Humulus lupulus Nutrition 0.000 description 1
244000061176 Nicotiana tabacum Species 0.000 description 1
235000002637 Nicotiana tabacum Nutrition 0.000 description 1
229920002701 Polyoxyl 40 Stearate Polymers 0.000 description 1
102000016611 Proteoglycans Human genes 0.000 description 1
108010067787 Proteoglycans Proteins 0.000 description 1
OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
102000004183 Synaptosomal-Associated Protein 25 Human genes 0.000 description 1
108010057722 Synaptosomal-Associated Protein 25 Proteins 0.000 description 1
241000209140 Triticum Species 0.000 description 1
235000021307 Triticum Nutrition 0.000 description 1
235000007251 Triticum monococcum Nutrition 0.000 description 1
238000002835 absorbance Methods 0.000 description 1
238000009825 accumulation Methods 0.000 description 1
230000035508 accumulation Effects 0.000 description 1
230000004913 activation Effects 0.000 description 1
238000004378 air conditioning Methods 0.000 description 1
238000003915 air pollution Methods 0.000 description 1
125000003275 alpha amino acid group Chemical group 0.000 description 1
230000004075 alteration Effects 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
150000001450 anions Chemical class 0.000 description 1
229940114079 arachidonic acid Drugs 0.000 description 1
235000021342 arachidonic acid Nutrition 0.000 description 1
238000003556 assay Methods 0.000 description 1
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
235000013871 bee wax Nutrition 0.000 description 1
239000012166 beeswax Substances 0.000 description 1
229940111759 benzophenone-2 Drugs 0.000 description 1
230000008827 biological function Effects 0.000 description 1
230000007321 biological mechanism Effects 0.000 description 1
230000033228 biological regulation Effects 0.000 description 1
WXNRYSGJLQFHBR-UHFFFAOYSA-N bis(2,4-dihydroxyphenyl)methanone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=C(O)C=C1O WXNRYSGJLQFHBR-UHFFFAOYSA-N 0.000 description 1
239000000872 buffer Substances 0.000 description 1
230000028956 calcium-mediated signaling Effects 0.000 description 1
230000030833 cell death Effects 0.000 description 1
230000024245 cell differentiation Effects 0.000 description 1
230000003915 cell function Effects 0.000 description 1
208000037887 cell injury Diseases 0.000 description 1
230000036978 cell physiology Effects 0.000 description 1
230000004663 cell proliferation Effects 0.000 description 1
230000003833 cell viability Effects 0.000 description 1
230000036755 cellular response Effects 0.000 description 1
229960000541 cetyl alcohol Drugs 0.000 description 1
229940125400 channel inhibitor Drugs 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
238000004040 coloring Methods 0.000 description 1
238000004891 communication Methods 0.000 description 1
210000002808 connective tissue Anatomy 0.000 description 1
229920001577 copolymer Polymers 0.000 description 1
ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
230000003247 decreasing effect Effects 0.000 description 1
230000007123 defense Effects 0.000 description 1
230000002939 deleterious effect Effects 0.000 description 1
239000011928 denatured alcohol Substances 0.000 description 1
239000007854 depigmenting agent Substances 0.000 description 1
210000004207 dermis Anatomy 0.000 description 1
230000004069 differentiation Effects 0.000 description 1
230000008034 disappearance Effects 0.000 description 1
235000021186 dishes Nutrition 0.000 description 1
239000002270 dispersing agent Substances 0.000 description 1
239000003937 drug carrier Substances 0.000 description 1
230000002500 effect on skin Effects 0.000 description 1
238000001962 electrophoresis Methods 0.000 description 1
230000008030 elimination Effects 0.000 description 1
238000003379 elimination reaction Methods 0.000 description 1
239000003974 emollient agent Substances 0.000 description 1
239000003995 emulsifying agent Substances 0.000 description 1
239000000839 emulsion Substances 0.000 description 1
230000002708 enhancing effect Effects 0.000 description 1
230000007613 environmental effect Effects 0.000 description 1
239000003344 environmental pollutant Substances 0.000 description 1
238000011156 evaluation Methods 0.000 description 1
230000005284 excitation Effects 0.000 description 1
MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
239000007850 fluorescent dye Substances 0.000 description 1
230000004907 flux Effects 0.000 description 1
230000002431 foraging effect Effects 0.000 description 1
239000003205 fragrance Substances 0.000 description 1
230000006870 function Effects 0.000 description 1
FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 1
235000011187 glycerol Nutrition 0.000 description 1
229940075529 glyceryl stearate Drugs 0.000 description 1
238000009499 grossing Methods 0.000 description 1
238000010438 heat treatment Methods 0.000 description 1
230000003054 hormonal effect Effects 0.000 description 1
239000003906 humectant Substances 0.000 description 1
239000008309 hydrophilic cream Substances 0.000 description 1
125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
238000010191 image analysis Methods 0.000 description 1
230000002779 inactivation Effects 0.000 description 1
239000004615 ingredient Substances 0.000 description 1
102000006495 integrins Human genes 0.000 description 1
108010044426 integrins Proteins 0.000 description 1
239000006210 lotion Substances 0.000 description 1
229920002521 macromolecule Polymers 0.000 description 1
229910052943 magnesium sulfate Inorganic materials 0.000 description 1
235000019341 magnesium sulphate Nutrition 0.000 description 1
238000012423 maintenance Methods 0.000 description 1
230000002503 metabolic effect Effects 0.000 description 1
210000001724 microfibril Anatomy 0.000 description 1
101150098783 mngA gene Proteins 0.000 description 1
238000012544 monitoring process Methods 0.000 description 1
230000037311 normal skin Effects 0.000 description 1
239000003921 oil Substances 0.000 description 1
239000003605 opacifier Substances 0.000 description 1
230000002018 overexpression Effects 0.000 description 1
230000003647 oxidation Effects 0.000 description 1
238000007254 oxidation reaction Methods 0.000 description 1
230000004792 oxidative damage Effects 0.000 description 1
239000001301 oxygen Substances 0.000 description 1
229910052760 oxygen Inorganic materials 0.000 description 1
238000009304 pastoral farming Methods 0.000 description 1
239000000575 pesticide Substances 0.000 description 1
239000000825 pharmaceutical preparation Substances 0.000 description 1
230000009894 physiological stress Effects 0.000 description 1
239000000049 pigment Substances 0.000 description 1
231100000719 pollutant Toxicity 0.000 description 1
229920002401 polyacrylamide Polymers 0.000 description 1
229940100518 polyglyceryl-4 isostearate Drugs 0.000 description 1
229920001296 polysiloxane Polymers 0.000 description 1
230000015323 positive regulation of phagocytosis Effects 0.000 description 1
239000000843 powder Substances 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
230000002265 prevention Effects 0.000 description 1
239000003380 propellant Substances 0.000 description 1
230000001681 protective effect Effects 0.000 description 1
230000005855 radiation Effects 0.000 description 1
238000011084 recovery Methods 0.000 description 1
230000008929 regeneration Effects 0.000 description 1
238000011069 regeneration method Methods 0.000 description 1
230000001105 regulatory effect Effects 0.000 description 1
230000004044 response Effects 0.000 description 1
230000011664 signaling Effects 0.000 description 1
229920005573 silicon-containing polymer Polymers 0.000 description 1
229920002545 silicone oil Polymers 0.000 description 1
210000004927 skin cell Anatomy 0.000 description 1
230000036620 skin dryness Effects 0.000 description 1
239000000779 smoke Substances 0.000 description 1
229940047670 sodium acrylate Drugs 0.000 description 1
239000007787 solid Substances 0.000 description 1
239000000126 substance Substances 0.000 description 1
239000000758 substrate Substances 0.000 description 1
230000000475 sunscreen effect Effects 0.000 description 1
239000000516 sunscreening agent Substances 0.000 description 1
208000024891 symptom Diseases 0.000 description 1
239000002562 thickening agent Substances 0.000 description 1
229940025703 topical product Drugs 0.000 description 1
238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Dermatology (AREA)
Birds (AREA)
Epidemiology (AREA)
Cosmetics (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

IE20060154A 2006-03-02 2006-03-02 Cosmetic compositions IES20060154A2 (en)

Priority Applications (2)

Application Number	Priority Date	Filing Date	Title
IE20060154A IES20060154A2 (en)	2006-03-02	2006-03-02	Cosmetic compositions
SE0700513A SE531484C2 (sv)	2006-03-02	2007-03-02	Kosmetiska kompositioner

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
IE20060154A IES20060154A2 (en)	2006-03-02	2006-03-02	Cosmetic compositions

Publications (1)

Publication Number	Publication Date
IES20060154A2 true IES20060154A2 (en)	2007-09-05

Family

ID=38457834

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IE20060154A IES20060154A2 (en)	2006-03-02	2006-03-02	Cosmetic compositions

Country Status (2)

Country	Link
IE (1)	IES20060154A2 (sv)
SE (1)	SE531484C2 (sv)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN116162135A (zh) *	2022-01-25	2023-05-26	上海中翊日化有限公司	一组性能优越的环肽及其应用

2006
- 2006-03-02 IE IE20060154A patent/IES20060154A2/en not_active IP Right Cessation
2007
- 2007-03-02 SE SE0700513A patent/SE531484C2/sv unknown

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN116162135A (zh) *	2022-01-25	2023-05-26	上海中翊日化有限公司	一组性能优越的环肽及其应用
CN116162135B (zh) *	2022-01-25	2023-09-26	上海中翊日化有限公司	一组性能优越的环肽及其应用

Also Published As

Publication number	Publication date
SE531484C2 (sv)	2009-04-21
SE0700513L (sv)	2007-09-03

Legal Events

Date	Code	Title	Description
2016-05-04	MK9A	Patent expired

Publication	Publication Date	Title
CA2749750C (en)	2014-01-28	Skin care compositions and methods of use thereof
Skibska et al.	2021	Signal peptides-promising ingredients in cosmetics
ES2421262T3 (es)	2013-08-30	Composición para el cuidado personal y cosmética que contiene tetrapéptidos con las unidades CX1X2G, PX1X2P o PX1X2K
US9115176B2 (en)	2015-08-25	Compounds, use thereof in cosmetic and cosmeceutic applications, and compositions comprising same
US11503840B2 (en)	2022-11-22	Peptide and saccharide hydrolysate of cocoa beans, cosmetic compositions containing same, and cosmetic uses of same
ES2540454T3 (es)	2015-07-09	Nuevos péptidos activadores de la síntesis de las proteínas de la matriz extracelular y composiciones cosméticas que los comprenden
CA2720542A1 (en)	2009-10-22	Cosmetic compositions comprising exopolysaccharides derived from microbial mats, and use thereof
JP6282582B2 (ja)	2018-02-21	皮膚老化の徴候を低減または遅延させるための、ジンゲロンまたはその誘導体の使用
WO2009003284A1 (en)	2009-01-08	Novel peptides, use thereof in cosmetic and cosmeceutic applications, and compositions comprising same
US8765689B2 (en)	2014-07-01	Anti-ageing peptides modulating survivin and compositions including same
IE20050411A1 (en)	2007-01-10	Cosmetic compositions containing lingonberry (vaccinium vitis idea) extracts
US11628133B2 (en)	2023-04-18	Uses of the peptide of sequence His-D-Trp-Ala-Trp-d-Phe-Lys-NH2 for reducing or delaying the appearance of cell senescence and signs of skin aging
KR101175803B1 (ko)	2012-08-24	피부세포 재생 및 주름개선 화장료 조성물
SE531484C2 (sv)	2009-04-21	Kosmetiska kompositioner
KR20260044412A (ko)	2026-04-02	자가포식 활성화 펩타이드를 유효성분으로 함유하는 주름 개선, 미백 또는 피부 보습용 화장료 조성물
WO2026052925A1 (fr)	2026-03-12	Nouvel ingrédient cosmétique et/ou dermatologique pour améliorer l'état, l'apparence et/ou le confort de la peau et/ou des muqueuses et/ou des phanères
CN118593376A (zh)	2024-09-06	一种抗皱紧致肌肤的组合物及其在化妆品中的应用
FR2995211A1 (fr)	2014-03-14	Utilisation d'agonistes des recepteurs opioides delta dans le domaine de la cosmetique et de la dermocosmetique
JP2004137191A (ja)	2004-05-13	皮膚外用剤
IES84572Y1 (en)	2007-05-02	Cosmetic compositions containing lingonberry (vaccinium vitis idea) extracts
HK1146730A (en)	2011-07-08	Novel compounds, use thereof in cosmetic and cosmeceutic applications, and compositions comprising same
HK1194397B (en)	2017-08-11	New peptides activating extracellular matrix protein synthesis and cosmetic compositions comprising same